VALIANT® Captivia VAMC3636C150TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMC3636C150TU VALCAP CLOSE · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169346857), received between Nov 3, 2020 and Jun 18, 2024 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Remove1
- Leak/Splash1
- Positioning Problem1
Patient problems
- Hemorrhage/Blood Loss/Bleeding1
- Insufficient Information1
- No Consequences Or Impact To Patient1
- Perforation of Vessels1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJun 18, 2024Difficult to Remove; Positioning Problem; Difficult to Remove; Positioning Problem
A VALIANT CAPTIVIA VAMC3636C150TU STENT GRAFT WAS INTENDED TO BE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A 70MM TAA . IT WAS NOTED THAT THE PATIENT HAD A PREVIOUS ASCENDING ARCH REPAIR WITH A DESCENDING THORACIC COMPONENT. IT WAS REPORTED THAT DURING THE INDEX PROCEDURE THE FIRST VALIANT CAPTIVIA STENT GRAFT (VAMF3232C200TU SERIAL # (B)(6) WAS PLACED WITH MINIMAL RESISTANCE AND DEPLOYED SUCCESSFULLY. HOWEVER THE SECOND VALIANT CAPTIVIA STENT GRAFT (VAMC3636C150TU, SERIAL# (B)(6) WENT TO THE MID EXTERNAL ILIAC AND HAD RESISTANCE. WHEN THE PHYSICIAN PUSHED THE DEVICE THE ARTERY CLAMPED DOWN ON THE DELIVERY SYSTEM AND THE NOSE CONE AND THE OUTER GRAFT COVER GAP WAS LONGER ON THE FLUOROSCOPY IMAGE. THE PHYSICIAN ATTEMPTED TO PULL THE DEVICE BACK AND ENCOUNTERED INCREASED RESISTANCE AND CONTINUED TO TRY TO REMOVE THE DEVICE BUT WITH NO SUCCESS. THE PATIENT'S BLOOD PRESSURE STARTED FALLING AND THE PHYSICIAN IMMEDIATELY PLACED A RELIANT BALLOON AND CARRIED OUT A RETROPERITONEAL INCISION TO REPAIR THE LEFT EXTERNAL ILIAC ARTERY. THE PHYSICIAN IDENTIFIED THAT THE ARTERY WAS STUCK IN THE GAP BETWEEN THE NOSE CONE AND THE DELIVERY S YSTEM AND LOOKED LIKE IT INSIDE OUT STUCK IN THE GRAF
Patient problems: Hemorrhage/Blood Loss/Bleeding; Insufficient Information; Perforation of Vessels
MAUDE report 19556654 ↗MalfunctionNov 3, 2020Leak/Splash; Leak/Splash
A VALIANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN 50MM FUSIFORM THORACIC AORTIC ANEURYSM. THE AORTA WAS NOTED AS SEVERELY TORTUOUS. IT WAS REPORTED APPROXIMATELY 5 YEARS POST THE INDEX PROCEDURE A DISTAL TYPE IB ENDOLEAK WAS IDENTIFIED. PER THE INVESTIGATOR THE CAUSE OF THE ENDOLEAK IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10777154 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page